A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

NCT03583606 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

NIH

Sponsor class

Conditions

Ebola Disease
Immunisation

Interventions

BIOLOGICAL: ChAd3-EBO-Z
BIOLOGICAL: MVA Multi-Filo Ebola Vaccine
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)